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Metalloprotease OMA1 Fine-
tunes Mitochondrial Bioenergetic 
Function and Respiratory 
Supercomplex Stability
Iryna Bohovych1,2, Mario R. Fernandez4, Jennifer J. Rahn5, Krista D. Stackley5, 
Jennifer E. Bestman5, Annadurai Anandhan2,3, Rodrigo Franco2,3, Steven M. Claypool6, 
Robert E. Lewis4, Sherine S. L. Chan5 & Oleh Khalimonchuk1,2
Mitochondria are involved in key cellular functions including energy production, metabolic 
homeostasis, and apoptosis. Normal mitochondrial function is preserved by several interrelated 
mechanisms. One mechanism – intramitochondrial quality control (IMQC) – is represented by 
conserved proteases distributed across mitochondrial compartments. Many aspects and physiological 
roles of IMQC components remain unclear. Here, we show that the IMQC protease Oma1 is required 
for the stability of the respiratory supercomplexes and thus balanced and tunable bioenergetic 
function. Loss of Oma1 activity leads to a specific destabilization of respiratory supercomplexes 
and consequently to unbalanced respiration and progressive respiratory decline in yeast. Similarly, 
experiments in cultured Oma1-deficient mouse embryonic fibroblasts link together impeded 
supercomplex stability and inability to maintain proper respiration under conditions that require 
maximal bioenergetic output. Finally, transient knockdown of OMA1 in zebrafish leads to impeded 
bioenergetics and morphological defects of the heart and eyes. Together, our biochemical and 
genetic studies in yeast, zebrafish and mammalian cells identify a novel and conserved physiological 
role for Oma1 protease in fine-tuning of respiratory function. We suggest that this unexpected 
physiological role is important for cellular bioenergetic plasticity and may contribute to Oma1-
associated disease phenotypes in humans.
Generation of ATP through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation 
(OXPHOS) is one of the vital mitochondrial functions. Electrons derived from the TCA cycle are fed 
into the OXPHOS system consisting of the electron transport chain (ETC) complexes (Complex I–IV) 
and ATP synthase (Complex V). Electron flux via the ETC units generates a proton gradient, which is 
subsequently used by Complex V to generate ATP1. Transfer of reactive electrons via the multiprotein, 
membrane-embedded ETC complexes is almost unavoidably linked to formation of superoxide radi-
cals generated by incomplete reduction of molecular oxygen - the final acceptor of electrons funneled 
through ETC2. These byproducts of respiration can be further converted into other potent radicals and 
are commonly known as reactive oxygen species (ROS). Perturbations in the electron transport can 
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further increase ROS production by ETC2. Accumulating or persisting ROS can damage biomolecules 
located in the vicinity of the ETC and cause mitochondrial dysfunction and disease3,4.
Individual ETC complexes are organized into so-called respiratory chain supercomplexes (RSCs) that 
localize to specific invaginations of the inner mitochondrial membrane (IMM) termed cristae5. The RSCs 
are believed to optimize electron channeling through ETC units and permit a robust use of various avail-
able substrates/electron donors, thereby assuring optimal and adaptable OXPHOS function6,7. It has also 
been postulated that RSCs help to enhance electron flux and minimize loss of the electrons - and thus 
ROS production - by ETC8,9. Relatively little is known about factors that promote and regulate formation 
and stability of RSCs. In yeast, stability of supercomplexes appears to be impacted by several factors: 1) 
phospholipid composition of IMM10–12; 2) subunits of cytochrome c oxidase (CcO, Complex IV)13,14; 3) 
ATP/ADP exchanger Aac215,16; and 4) IMM-anchored proteins Rcf1 and Rcf29,13,17. Similar factors seem 
to contribute to RSCs’ stability in mammals. A recent study identified an important role of cristae and 
cristae-remodeling factors like IMM GTPase OPA1 in assembly and stability of mammalian RSCs18.
A subset of conserved proteases is involved in maintenance of protein homeostasis in the IMM4,19. 
IMM-anchored m-AAA, i-AAA and Oma1 metalloproteases have been implicated in proteolytic con-
trol of ETC assembly/stability4,20–22. These enzymes mediate proteolysis and removal of misfolded or 
unassembled OXPHOS subunits, thereby preventing malformation of dysfunctional ETC units, which 
upon accumulation can affect electron flux, promote excessive ROS production and negatively impact 
IMM integrity4. While Oma1 is known to mediate degradation of hypo-hemylated Cox1 CcO subunit 
in yeast20,23, its primary role in metazoans appears to be proteolytic processing of OPA124–27. However, 
the diversity of phenotypes associated with Oma1 loss28,29 suggests that the protease might be playing 
additional roles in mitochondrial physiology.
Here, we describe a novel role of Oma1, wherein this ATP-independent protease is involved in stabi-
lization of RSCs at different stages of life. Yeast cells deficient in Oma1 display decreased supercomplex 
stability, unbalanced respiration and progressive respiratory decline during aging. Studies in zebrafish 
and mammalian cell culture models further support our conclusions and suggest a conserved physiolog-
ical role of Oma1 in fine-tuning of respiratory function in metazoans through control of RSCs stability/
performance. Our data provide novel insights into the physiological significance of Oma1 in cellular 
health and protection against aging-associated mitochondrial degeneration.
Results
Progressive respiratory decline in the aging oma1Δ mutant. Our group and others have pre-
viously reported that loss of Oma1 function in yeast does not result in any appreciable phenotype under 
normal growth conditions23,26,28. However, Oma1 proteolytic activity is important for cellular tolerance 
to various conditions of mitochondrial stress28. It was shown that Oma1 function is critical for stationary 
phase survival of yeast cells deficient in m-AAA or i-AAA proteases, as well as manganese superoxide 
dismutase Sod226,28. We also noticed that activity, but not abundance of the oxidative damage-suscepti-
ble enzyme aconitase tended to decrease in Oma1-deficient cultures maintained into stationary phase 
(Ref. 28 and data not shown). Consistent with the role of Oma1 in mitochondrial health in stationary 
phase, we observed destabilization of the Oma1 oligomeric complex from these cells by BN-PAGE, as 
compared to the oligomer in mitochondria from log phase cells (Fig. 1A). Steady-state levels of the pro-
tease were similar in each case. Changes in Oma1 oligomer stability upon BN-PAGE reflect the enzyme’s 
activation28 and indicate that the protease is more active in stationary cells. We hypothesized that Oma1 
deficit may lead to age-associated decline of mitochondrial health. Cell survival in stationary phase heav-
ily depends on ATP generated via mitochondrial respiration30. We thus examined time-dependent main-
tenance of respiratory competence by wild type (WT) and oma1Δ cells. Respective strains were cultured 
for a period of 12 hours (log phase), 4 days (stationary phase) or 8 days (late stationary phase) and tested 
for their ability to propagate on plates containing a non-fermentable glycerol/lactate mix. Respiratory 
growth of the oma1Δ mutant was comparable to WT at both 12 hours and 4 days of culture, but at day 
8 of culture we observed significant decrease in the ability of oma1Δ mutant to propagate on glycerol/
lactate plates (Fig.  1B). Glucose growth of WT and oma1Δ cells was normal at all culturing periods 
tested. This result suggests specific time-dependent impairment of respiratory function in oma1Δ strain. 
To substantiate our conclusion, we quantitatively assessed the ability of WT and oma1Δ strains to form 
viable colonies on glycerol/lactate medium upon prolonged culturing. No significant difference in res-
piratory survival of the strains was observed after 2 or 4 days of culture. In contrast, oma1Δ mutant 
exhibited substantial decline in survival on glycerol/lactate medium after 8 days of culture (Fig. 1C). The 
survival of oma1Δ cells on the plates containing glucose or galactose was not affected (Supplementary 
Fig. S1A and data not shown). Exponentially growing oma1Δ cells displayed about two-fold increase 
in endogenous superoxide (as indicated by staining with O2−-specific dye dihydroethidium) than WT 
strain (Fig.  1D), thereby implicating ROS as a likely contributor to observed respiratory decline. We 
then tested mitochondrial respiration of WT and oma1Δ strains at different stages of growth in galac-
tose-containing medium. Galactose is a fermentable carbon source, which however, does not repress 
mitochondrial function. Surprisingly, the oma1Δ mutant displayed significantly higher rate of oxygen 
consumption in the log phase (12 h of culture), as compared to WT (Fig.  1E). However, in stationary 
phase (4 days of culture) oma1Δ cells displayed marked decrease in oxygen consumption (Fig.  1E), 
indicating mitochondrial impairment. In line with respiratory imbalance, the oma1Δ mutant exhibited 
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alterations in mitochondrial membrane potential, as indicated by higher percentage of depolarized cells 
during exponential growth (Fig. 1F). These data demonstrate that cells lacking Oma1 have unbalanced 
respiration and are prone to a gradual decline of respiratory function with age.
Loss of Oma1 affects the stability of RSCs without impeding individual ETC units. To gain 
more insights into the role of Oma1 in respiration, we conducted a thorough analysis of the ETC func-
tion in oma1Δ mutant at both log and stationary phases of growth. Steady-state levels of key subunits of 
OXPHOS complexes were unaffected by loss of Oma1 in both galactose and glucose cultures (Fig. 2A). 
Similarly, mitochondrial translation rates and stability of newly synthesized Complex IV (Cox1, Cox2, 
Cox3), Complex III (Cytochrome b) and Complex V (Atp6) subunits in oma1Δ mutant were com-
parable to WT (Supplementary Fig. S1B). BN-PAGE analysis of individual OXPHOS units (obtained 
through lysis of the respective mitochondria with 1% dodecylmaltoside) also did not reveal significant 
differences in abundance or stability of these complexes in the oma1Δ strain (Fig. 2B). Equally, specific 
enzymatic activities of CcO (Complex IV), bc1 cytochrome c reductase (Complex III) and succinate 
dehydrogenase (Complex II) were similar in both WT and oma1Δ mitochondria (Supplementary Fig. 
S1C-S1E). These data indicate that unbalanced respiration seen in the oma1Δ mutant is most likely not 
due to an impairment of individual OXPHOS units. Next, we examined if observed oxygen consumption 
imbalance in oma1Δ, cells may be due to compromised integrity of Complex III/Complex IV RSCs – a 
Figure 1. Deletion of Oma1 leads to progressive mitochondrial dysfunction. (A) Electrophoretic analyses 
of mitochondria from wild-type (WT) strain with Oma1-13xMyc chromosomal tag isolated at exponential 
(12 h post-inoculation, A600 of 0.8; Log.) and stationary (48 h post-inoculation, A600 of 8.0; Stat.) phases  
of growth. Mitochondria (70 μ g) were solubilized with 1.5% digitonin and subjected to BN-PAGE; 20 μ g of 
mitochondria were used for SDS-PAGE. Oma1 was detected by immunoblotting with anti-Myc. Monomeric 
form of Complex V (V; BN-PAGE loading control) visualized with anti-F1 serum; porin was SDS-PAGE 
loading control. Source data (full-length blots) are available online in Supplementary information.  
(B) Respiratory growth of WT and oma1Δ strains. Synchronized cells were cultured in YPD medium for 
0.5 (12 hours), 4 and 8 days at 28 °C and spotted onto YPD (Glucose) or YPGL (Glycerol/Lactate) plates. 
Pictures taken after 2 (YPD) or 4 (YPGL) days of growth at 28 °C. (C) WT and oma1Δ strains were grown 
in YPD medium for indicated number of days, diluted to 600 cells and plated on YPGL plates. Following a 
4-days incubation at 28 °C, number of colony forming units was determined (n = 3 biologically independent 
experiments). The values were normalized to number of colonies that each strain formed when cultured on 
glucose-supplemented plates. (D) Endogenous superoxide levels in WT and oma1Δ cells. Log-phase cells 
stained with O2.−-specific dye dihydroethidium (DHE) were analyzed by flow cytometry (n = 4). (E) Oxygen 
consumption of synchronized WT and oma1Δ cells at log (A600 of 0.8) and stationary (A600 of 8.0) stages 
of growth; n = 3 independent cultures per each strain. (F) Mitochondrial membrane potential of WT and 
oma1Δ strains during log and stationary growth, assessed by flow cytometry analysis of JC-1-stained cells 
(n = 3). Data represent mean values ± S.D. **p < 0.01, *p < 0.05, n.s. =  non-significant (t-test).
www.nature.com/scientificreports/
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condition that is known to affect respiratory rates31. Synchronized WT and oma1Δ strains were cultured 
in galactose-containing media to promote mitochondrial function and mitochondria were isolated from 
respective cells harvested at either log or stationary phases. The organelles were lysed in mild non-ionic 
detergent digitonin to preserve RSCs. Consistent with previous report9, BN-PAGE of WT lysates showed 
that in the log phase both Complex III (anti-Rip1 immunoblot) and Complex IV (anti-Cox2 immunob-
lot) associate into III2/IV2 tetramer and, to a smaller extent, into III2/IV trimer. Abundance of the latter 
RSC increased and some dimeric Complex III was also seen in the stationary phase in WT mitochondria 
(Fig. 2C). In contrast, analysis of RSCs in oma1Δ mutant revealed marked reduction in III2/IV2 super-
complex in log stage and III2/IV supercomplex in stationary stage, respectively. In addition, we observed 
accumulation of free Complex IV in stationary oma1Δ cells (Fig.  2C), indicating that RSCs are likely 
less stable under BN-PAGE conditions if Oma1 is lost. Migration patterns of Complex V (monomer and 
dimer) were comparable between WT and oma1Δ cells. To confirm that the observed RSCs’ stability 
defect arises from Oma1 deficit, we examined the distribution of III/IV supercomplexes in oma1Δ cells 
expressing WT protease or its catalytic H203A mutant28. As shown in Fig. 2D, despite the fact that either 
Oma1 variant was present at similar levels, only the expression of WT protease but not its catalytic 
mutant, stabilized the III/IV RSCs. Together, our data demonstrate that loss of Oma1 function impairs 
the stability of RSCs. Oma1 does not appear to be a stoichiometric component of RSCs as no interaction 
between the protease and subunits of ETC complexes was observed (Ref. 20 and data not shown).
OMA1 genetically interacts with RSCs-stabilizing factors. We sought to identify factors that 
may contribute to RSCs destabilization seen in Oma1-deficient cells. Factors known to impact RSCs’ 
stability include phospholipid composition of the IMM and several IMM-anchored proteins like Rcf1/
Figure 2. Respiratory supercomplexes are impaired in Oma1-deficient yeast cells. (A) Steady-state levels 
of the Cox1-Cox3 subunits of CcO (Complex IV), Cyt1 and Rip1 subunits of bc1cytochrome c reductase 
(Complex III), Sdh2 subunit of succinate dehydrogenase (Complex II), and Atp2 subunit of F1FO ATP 
synthase (Complex V), and porin were assessed by immunobloting of mitochondria (20 μ g) from WT and 
oma1Δ cells. (B) BN-PAGE of individual ETC complexes from log and stationary phase WT and oma1Δ 
cells. Mitochondria (40 μ g) were solubilized with 1% dodecyl maltoside (DDM). The complexes were 
visualized by blotting with indicated antibodies. (C) BN-PAGE of the above mitochondria lysed with 1.5% 
digitonin. (D) oma1Δ cells bearing vector, Myc-tagged Oma1 or its H203A variant were grown in synethetic 
galactose medium and used for mitochondrial isolation. Mitochondria (70 μ g) were analyzed by BN-PAGE 
as in C. Another 20 μ g of mitochondria were used for SDS-PAGE. Source data (full-length blots) are 
available online in Supplementary information.
www.nature.com/scientificreports/
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HIG1 and Rcf2/HIG29,13,17, ATP/ADP carrier Aac215,16 and Complex III/IV interface-mediating protein 
Cox1331. The impediment in RSCs’ stability seen in oma1Δ mutant was not due to changes in mito-
chondrial phospholipid content or altered phospholipid/protein ratio (Supplementary Fig. S2A, B). We 
thus focused on analysis of genetic interactions of OMA1 with genes encoding factors that are known 
to influence the stability of III/IV RSCs. First, we examined the ability of aforementioned molecules 
to stabilize labile RSCs in oma1Δ mutant. Overexpression of RCF1, but not genes encoding other 
RSCs-stabilizing factors like CcO subunit Cox5a, stabilized the III/IV supercomplexes in mitochondria 
isolated from log-phase oma1Δ cells (Fig. 3A and not shown). Reciprocally, loss of Rcf1 in oma1Δ back-
ground further compromised stability of RSCs in this strain (Fig. 3B). Such destabilization is likely due to 
affected stability of the core subunits of Complex IV, as indicated by anti-Cox2 immunoblot (Fig. 3A and 
Supplementary Fig. S2C). We then tested the genetic relationship between Oma1 and RSCs-stabilizing 
factors in greater detail. Because some single deletion mutants in question are unable to grow efficiently 
on non-fermentable media, we employed a previously reported approach, whereby stationary phase sur-
vival of double deletion strains on glucose-containing plates is used as readout for respiratory capac-
ity9,30. We constructed a series of strains lacking Oma1, Rcf1, Cox13, or Aac2 in different combinations. 
Respective deletion mutants were tested for survival on glucose plates at 28 °C and 37 °C. When grown to 
log stage, all strains displayed normal growth at tested conditions (Fig. 3C and data not shown). Similarly, 
when tested at day 6 of stationary phase, oma1Δ , rcf1Δ and cox13Δ mutants as well as aac2Δ oma1Δ , 
rcf1Δ aac2Δ , cox13Δ oma1Δ and rcf1Δ oma1Δ cox13Δ strains grew normally at both 28 °C and 
37 °C. Growth of aac2Δ mutant was slightly delayed at 37 °C. In contrast, stationary phase-grown rcf1Δ 
oma1Δ aac2Δ triple mutant showed profound survival defect at either temperature (Fig.  3C). Similar 
results were obtained when cells were cultured on galactose plates (not shown).
Our observation that the aac2Δ mutant, but not the aac2Δ oma1Δ strain exhibited 37 °C growth 
defect suggests that loss of OMA1 may have an alleviating effect in the aac2Δ background. We thus 
examined the ability of these strains to propagate on fermentative (glucose), non-repressive (galac-
tose) and respiratory (glycerol/lactate) media. Consistent with previous report32, the aac2Δ strain grew 
poorly on galactose medium and was unable to form viable colonies on YPGL plates. Conversely, the 
oma1Δ aac2Δ mutant displayed robust growth on YPGL medium, indicating that loss of Oma1 can 
alleviate Aac2 deficiency (Fig. 3D). Notwithstanding positive genetic effect, RSCs in the aac2Δ oma1Δ 
mutant remained unstable (not shown). As expected, deletion of RCF1 in aac2Δ oma1Δ strain ablated 
the suppressive effect of Oma1 loss (not shown). These data demonstrate genetic interaction between 
RCF1, AAC2 and OMA1 suggesting that products of these genes may act either in parallel or at different 
steps to promote RSCs stability. However, because Aac2 plays several important roles in mitochondrial 
Figure 3. OMA1 genetically interacts with supercomplex-stabilizing factors. (A) BN- and SDS-PAGE 
analysis of mitochondria from log-phase oma1Δ cells expressing OMA1, overexpressing RCF1 or COX5a. 
Source data (full-length blots) are available online in Supplementary information. (B) Mitochondria 
from log-phase wild-type (WT), oma1Δ rcf1Δ and rcf1Δ oma1Δ cells were analyzed by native (70 μ g of 
mitochondria) or denaturing (20 μ g of mitochondria) PAGE. (C) Indicated strains were cultured in YPD 
medium for 0.5 (12 hours) and 8 days at 28 °C, spotted onto YPD (Glucose) plates and incubated at 28 °C 
or 37 °C. Pictures were taken after 2 days of growth. (D) The indicated strains were dropped onto YPD 
(Glucose), YPGal (Galactose) and YPGL (Glycerol/Lactate) plates and incubated at 28 °C.
www.nature.com/scientificreports/
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physiology33, observed genetic interaction may not be solely attributed to the molecule’s role in RSCs 
stabilization and will be a subject of future analyses.
Loss of Oma1 leads to developmental defects in zebrafish model. To better understand 
the physiological role of Oma1 in context of metazoan animal development, we examined effects of 
Oma1 depletion in a Danio rerio vertebrate model. Four-cell stage fish embryos from the same breed-
ing pairs were injected with either control, or zfoma1-specific translation blocking morpholinos (MO). 
Initial analysis of embryos at 72 hours post fertilization (hpf) revealed that unlike control morphants, 
Oma1-depleted fish presented with pericardial edema, smaller eyes and shorter body length (Fig. 4A–C). 
Immunoblotting of protein extracts from de-yolked embryos with antibodies against human OMA1 (also 
recognizes the fish homolog) confirmed an efficient depletion of the protease (Fig.  4D). The highest 
reduction of Oma1 levels was observed at 24 and 48 hpf. At 72 hpf, intensity of the Oma1 band in the 
zfoma1 morphant was increased, likely due to decreased MO effectiveness. Steady-state levels of Cox4, a 
key CcO subunit, and Actin were comparable in each case (Fig. 4D). We next examined abundance and 
distribution of the known OMA1 substrate, OPA1. Consistent with a previous report34, multiple isoforms 
of the protein were detected. Distribution of Opa1 isoforms was comparable between control and Oma1 
morphants at all times tested (Fig. 4D). Interestingly, the abundance of Opa1-specific bands was slightly 
increased in zfoma1-treated embryos. Together, these data demonstrate that Oma1 depletion in fish leads 
to a series of organ developmental defects characteristic of mitochondrial dysfunction. Observed defects 
do not appear to be due to instability or changes in basal processing of Opa1, or CcO subunits.
Phenotypic and bioenergetics analysis of zfoma1 morpholino-treated zebrafish embryos. 
Because the most efficient depletion of Oma1 is seen at 24–72 hpf, we sought to analyze phenotypic con-
sequences of zfoma1 MO treatment at these stages of life. At 24 hpf, zfoma1 morphants did not exhibit 
significant differences in cardiac morphology as compared to control embryos. This is likely due to the 
fact that zebrafish hearts are still developing at this stage. However, we observed substantial graininess of 
the neural tube in zfoma1 MO fish, which reflects brain abnormality (Fig. 5A,B). Such abnormality was 
Figure 4. Depletion of Oma1 in fish affects development. (A,B) Representative images of larval zebrafish 
at 72 hours post fertilization (hpf) injected with either a standard control MO (A) or a zfoma1 MO (B). Fish 
injected with zfoma1 MO have smaller heads and eyes (red arrow) and defects in heart morphology (blue 
arrow). Bar, 500 μ m. (C) Body length of control and zfoma1 morphants at 72 hpf. Average standard length 
was plotted ± S.E.M. (n = 6–13, **p < 0.01 by t-test). (D) Immunoblot of protein extracts from injected fish 
(yolk removed) at 24, 48 and 72 hpf. Expression of Oma1, Opa1 isoforms (a–f) and Cox4 (mitochondrial 
abundance marker) was analyzed with respective antibodies. Actin and Ponceau S staining were loading 
controls. Source data (full-length blots) are available online in Supplementary information.
www.nature.com/scientificreports/
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Figure 5. Depletion of Oma1 in fish results in specific developmental abnormalities. (A–L) At 24 hpf, 
zfoma1 morphants (B) lack definition of brain structures (blue arrow) compared to control MO fish (A). At 
48 hpf, several abnormalities are observed in Oma1 MO-injected embryos (D,F,H). The embryos had smaller 
heads and eyes and often exhibited pericardial edema (blue arrow, D,F) that sometimes resulted in visible 
erythrocyte accumulation in the yolk sinus area (red asterisk, H). Pigmentation in the eye was partially 
complete compared to controls (red arrow, F). At 72 hpf, pericardial edema was extensive (blue arrow,  
J,L) and hearts were largely unlooped. Scale bars, 200 μ m. (M) Eye size in control and zfoma1 morphants at 
24, 48 and 72 hpf (n = 9–12). (N) Heart contraction rates (measured as beats per minute) in control versus 
Oma1-depleted fish at 48 and 72 hpf (n = 30). (O) In vivo respiration in control and Oma1 MO-treated fish 
embryos at 24, 48 and 72 hpf (n= 10). Data are shown as mean ± S.E.M.; *p < 0.05, **p < 0.01, ***p < 0.001 
zfoma1 vs. control MO (t-test).
www.nature.com/scientificreports/
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not pronounced at 48 hpf. However, we noticed that Oma1-depleted fish exhibited significantly smaller 
and slightly sectored eyes (Fig. 5C–H). In addition, at both 48 and 72 hpf, zfoma1 MO-treated embryos 
displayed pericardial edema (Fig. 5C–L) that was often accompanied by accumulation of red blood cells 
in the yolk sinus area (Fig. 5H, red asterisk), suggesting impeded blood circulation. Quantitative assess-
ment of eye sizes in control and Oma1 morphants revealed that the latter animals had significantly 
smaller eyes at all stages tested (Fig. 5M). Likewise, heart contractility of 48 and 72 hpf zfoma1 MO fish 
- as reflected by decreased heart rate - was lower when compared to control (Fig. 5N).
The Oma1 morphants exhibit phenotypes known to associate with bioenergetic defects34,35. We thus 
interrogated rates of oxygen consumption (OCR) - a proxy for mitochondrial respiratory function - by 
control and Oma1-deficient embryos. Basal OCR for respective morphants at 24–72 hpf were deter-
mined using XF24 extracellular flux analyzer36. At 24 and 72 hpf, respiration was substantially decreased 
in Oma1-depleted embryos, when compared to control (Fig. 5O). Of note, we observed that at 48 hpf, 
OCRs of control and Oma1 morphants were not significantly different, likely due to a compensatory 
mechanism. These data indicate that eye and cardiovascular developmental defects seen in zfoma1 MO 
fish arise from an impaired bioenergetic function.
Impaired bioenergetics capacity in oma1−/− MEFs. Based on the above observations, we hypoth-
esized that developmental defects seen in Oma1 morphants can be - at least in part - due to mitochon-
drial deficits caused by destabilized RSCs. Because an in-depth analysis of mitochondrial function in fish 
embryos is challenging, we instead decided to address this question by using oma1−/− mouse embryonic 
fibroblasts (MEFs). A previous study29 reported that cells derived from oma1−/− mice do not exhibit 
significant respiratory deviations upon standard culturing (in presence of glucose and glutamine). Under 
these conditions, fibroblasts derive ATP from both aerobic glycolysis and glutamine oxidation37 (Fig. 6A). 
However, as suggested by our analyses in yeast, consequences of Oma1 deficit may become apparent only 
when cells primarily rely on OXPHOS. We thus measured OCR by WT and oma1−/− MEFs cultured in 
media containing 10 mM glucose or 10 mM galactose. Either condition is known to force cells to switch 
towards glutaminolysis and mitochondrial respiration37,38. No significant differences between basal OCR 
and ATP production rates (measured as OCR due to inhibition of ATP synthase with oligomycin) in WT 
and oma1−/− MEFs were seen under each condition tested (Fig. 6B,C). Nevertheless, when MEFs were 
incubated with the drug FCCP - to uncouple ETC from the proton gradient and thus determine maximal 
OXPHOS activity - we observed that oma1−/− MEFs were unable to increase their OCR in response to 
the treatment (Fig. 6B,C). Of note, FCCP treatments of oma1−/− MEFs cultured in 10 mM galactose were 
unable to restore OCR to basal levels as observed for WT MEFs. Moreover, the observation that FCCP 
did not increase OCR above basal levels in WT MEFs (in comparison to WT MEFs cultured in 10 mM 
glucose) indicates that 10 mM galactose-grown MEFs have already maximized OXPHOS. Together, these 
data suggest that Oma1-deficient mitochondria are unable to perform at peak respiratory capacity, when 
maximal flux via the ETC is allowed. We also noticed that when cultured in 10 mM glucose-containing 
medium, oma1−/− MEFs exhibited higher extracellular acidification rate (ECAR) upon oligomycin or 
FCCP-treatments (Supplementary Fig. S3A, S3B), reflecting enhanced compensatory aerobic glycolysis. 
Incubation of cells with glycolysis inhibitor 2-deoxyglucose decreased ECAR to levels seen with WT 
fibroblasts, indicating that glycolytic reserve of oma1−/− MEFs was not altered (Supplementary Fig. S3C). 
To substantiate our findings, we determined the ratio between FCCP-uncoupled OCR and basal OCR, 
known as respiratory control ratio (RCR) - an established measure of mitochondrial efficiency39. RCR 
was significantly lower for oma1−/− MEFs cultured in medium containing 10mM glucose compared to 
WT cells (Fig.  6D). A similar pattern was observed for galactose-grown MEFs (Fig.  6E). Importantly, 
these findings parallel bioenergetic defects seen in zfoma1 MO-treated fish embryos.
Mammalian OMA1 is required for RSCs stability. We next tested if the inability to maximize ETC 
performance seen in oma1−/− MEFs might arise from destabilized RSCs. BN-PAGE of mitochondrial 
lysates from WT and oma1−/− MEFs revealed that the abundance of the I/III2/IV2 and I/III2/IV RSCs 
was decreased in the latter cells (Fig. 7A). This attenuation appears to be related to a depletion or desta-
bilization of RSCs that contain Complexes I, III and IV; assemblies that lack these complexes (Complex 
V) remained unperturbed in oma1−/− MEFs. At the same time, levels of individual Complexes I, III, IV 
(Fig. 7B), and steady-state levels of representative subunits (Fig. 7C) were largely unchanged. These data 
indicate that the role of Oma1 in stabilization of RSCs observed in the yeast model is conserved in higher 
eukaryotes. Bioenergetic deficits observed in oma1−/− MEFs and zebrafish model are likely consequences 
of an unbalanced ETC due to impeded stability of RSCs. The molecular bases of Oma1-mediated RSCs’ 
stabilization in metazoans will be a focus of future studies.
Discussion
Conserved metalloprotease Oma1 was shown to mediate stress-triggered proteolytic processing of 
IMM-anchored proteins in both yeast and mammals24–28,40. However, reported stress conditions used 
to mimic mitochondrial dysfunction and trigger Oma1 activation are often extreme and borderline to 
non-physiological. While useful for obtaining initial mechanistic insights, this approach leaves many 
aspects of Oma1′ s physiological significance unaddressed. Here, we conducted experiments aiming to 
unveil additional physiological roles of Oma1. We show herein that Oma1 activity is required for stability 
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of RSCs in both yeast and metazoans. Such stabilization appears to be critical for optimal ETC function 
and respiration at maximal capacity. Several lines of evidence support these conclusions.
First, stationary yeast cells deficient in Oma1 exhibit progressive respiratory decline. Although this 
finding per se provides only indirect evidence, it is further strengthened by observed imbalance in oxygen 
consumption displayed by oma1Δ mutant in both log and stationary phase of growth. Mitochondrial 
respiration is enhanced and is critical for survival of yeast cells in stationary phase30. It is plausible that 
accumulating respiratory deficit will lead to a growth defect on non-fermentable media. Noteworthy, 
observed decrease in oxygen consumption by stationary phase oma1Δ strain is seen prior to any respira-
tory growth defects displayed by these cells. Activation-associated destabilization of the Oma1 complex 
by BN-PAGE observed in stationary WT cells also indicates the importance of Oma1 for respiratory 
survival during aging. Curiously, a similar respiratory imbalance pattern has been previously reported in 
mutants defective in nutrient-sensing TOR signaling as well as yeast cells subjected to dietary restriction 
regimen41. It will be interesting to test whether there is a link between Oma1′ s function and TOR signal-
ing. The above findings are paralleled by the results of immunoblot analyses of oma1Δ mitochondria from 
log versus stationary cells. The oma1Δ mutant does not display any significant impediment in biogenesis, 
stability, specific enzymatic activity, or abundance of individual ETC complexes or their core (and pre-
sumably supernumerary) subunits. However, BN-PAGE analyses of digitonin extracts suggest that RSCs 
are less stable in the absence of Oma1. Importantly, similar destabilization is observed in mitochondria 
isolated from oma1−/− MEFs. These data demonstrate evolutionary conservation of Oma1′ s role in the 
stabilization of RSCs. The mechanism of Oma1-mediated RSCs stabilization remains to be clarified. It 
does not seem to involve phospholipids or changes in the IMM’s lipid to protein ratios. Likewise, direct 
Figure 6. Impaired bioenergetic function in oma1−/− MEFs. (A) Schematic of cellular energy-converting 
pathways and inhibitors used to profile MEFs’ bioenergetics. FCCP, carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone; OLA, oligomycin A. (B,C) Oxygen consumption rates (OCR) in wild type (OMA1+/+) 
and oma1−/− MEFs under basal, OLA- and FCCP-stimulated conditions. Cells were cultured in the media 
containing 10 mM glucose (B) or 10 mM galactose (C). Data are shown as mean ± S.E.M. (n = 3 biological 
replicates); *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired t-test). (D,E) Respiratory control ratios (a ratio 
between FCCP-stimulated OCR and basal OCR) in OMA1+/+ and oma−/− cells cultured in 10 mM glucose 
(D) or 10 mM galactose (E). Error bars indicate S.D.; p values are relative to control.
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physical association of Oma1 with RSCs seems unlikely20. The mechanism clearly involves the enzyme’s 
proteolytic function, as the expression of catalytically inactive Oma1 does not confer RSCs’ stability.
Second, our study reveals genetic interaction between Oma1 and Rcf1 - a factor, which was shown 
previously to mediate the stability of RSCs9,13,17. Moreover, OMA1 displays strong genetic interaction 
with AAC2, another molecule implicated in stabilization of RSCs15,16. Loss of Oma1 in Aac2 deletion 
mutant results in a robust synthetic rescue effect and restores respiratory competence of the aac2Δ strain. 
Interestingly, this genetic effect is not associated with stabilization of RSCs. Because Aac2 plays other 
(distinct from RSCs stabilization) important roles in mitochondrial physiology32,33, the observed genetic 
interaction may not be fully related to RSCs’ stability and requires additional investigation. Nonetheless, 
1) the fact that rescue effect seen in aac2Δ oma1Δ strain is ameliorated by depletion of RCF1; and 2) 
strong synthetic interaction between these three genes in stationary phase survival growth assays, are 
consistent with the postulated role of Oma1 in RSCs stabilization. Of note, we did not observe strong 
synthetic interaction between RCF1 and AAC2 reported previously9. This is likely due to differences in 
genetic background of strains used in these analyses.
Third, our studies in MEFs demonstrate that loss of Oma1 in mammalian cells appears to have similar 
outcomes. In agreement with previous report29, under standard cultivation conditions, basal OCRs of 
oma1−/− MEFs are similar to those of WT cells. This is probably due to the ability of MEFs to generate 
ATP from both aerobic glycolysis and mitochondrial glutamine oxidation37. However, when oma1−/− 
cells are forced to rely primarily on mitochondrial function by lowering glucose in the medium or 
replacing it with galactose, the bioenergetic deficit becomes evident. The most striking difference is seen 
upon uncoupling of cells with FCCP – the condition that maximizes ETC function. Consistent with 
bioenergetic impediment, this condition significantly enhances aerobic glycolysis in oma1−/− but not in 
WT MEFs cultured in low glucose. One explanation is that upon uncoupling, Oma1-mediated cleavage 
of L-OPA1 – an important event necessary for cristae remodeling24,27,29,42 – may be also required for 
subsequent OXPHOS “re-tuning”. Inability to remodel mitochondrial cristae via proteolysis of OPA1 
under these conditions could be the reason for the observed effects. Indeed, IMM cristae and OPA1 were 
shown recently as important mediators of RSCs formation and respiratory efficiency18,43. On the other 
hand, preservation of long OPA1 isoform and thus robust cristae ultrastructure is viewed as a benefit 
and was shown to be protective against mitochondrial damage27,29,44. Perhaps the role of Oma1 in RSCs 
stability is not restricted to OPA1 processing and may involve a different mechanism. Consistent with 
this hypothesis is our observation that Oma1-mediated stabilization of RSCs also occurs in yeast even 
though the fungal OPA1 homolog, Mgm1, is not a substrate of yeast Oma145–47. Similarly, bioenergetic 
defects seen in Oma1-depleted fish embryos do not seem to arise primarily from impaired OPA1 pro-
cessing. Future analyses will address the question of how condition-induced Oma1-mediated processing 
of OPA1 impacts the stability of respiratory supercomplexes in mammalian cells.
Figure 7. Loss of OMA1 impairs mammalian RSCs. (A) BN-PAGE of mitochondria from wild type 
(OMA1+/+) and oma1−/− MEFs. Mitochondria (80 μ g) were solubilized with 2% digitonin. Protein complexes 
were visualized with antibodies to NDUFA9 (Complex I), CORE1 (Complex III), MTCO1 (Complex 
IV) and ATP5A (Complex V). (B) BN-PAGE of WT and oma1−/− mitochondrial lysates. Mitochondria 
(40 μ g) were solubilized with 1% dodecyl maltoside (DDM). Individual ETC complexes were visualized 
by immunoblotting with indicated antibodies. (C) Steady-state levels of the indicated subunits of ETC 
complexes in WT and oma1−/− mitochondria. Ten and 15 μ g of mitochondria were analyzed by SDS-
PAGE. Source data (full-length blots) for key panels of this figure are available online in Supplementary 
information.
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Finally, results of our experiments in a zebrafish model underscore the physiological significance 
of Oma1 in supporting proper respiratory function during embryogenesis. Oma1-deficient fish exhibit 
developmental abnormalities, which are hallmarks of impeded energy metabolism and mitochondrial 
disease34, 35,48. Consistent with the idea that bioenergetic deficit is driving observed developmental defects; 
zfoma1 morphants display significantly decreased OCR. This impediment is particularly pronounced at 
72 hpf stage wherein fish embryos become more dependent on respiration36.
In conclusion, our studies in yeast, zebrafish and mammalian cells suggest a novel and conserved 
physiological role for Oma1, whereby this ATP-independent protease is involved in stabilization of RSCs 
and fine-tuning of respiratory function in eukaryotes during various stages of life. Our data provide 
important insights into physiological significance of Oma1 in cellular health and protection against 
aging-associated mitochondrial degeneration. We anticipate that these findings might enable new bene-
ficial approaches to enhance mitochondrial health in aging cellular populations.
Methods
Yeast Strains, Vectors and Media. This study used Saccharomyces cerevisiae strains isogenic to the 
W303-1B (MATα ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1) genetic background. The strains used are 
listed in Supplementary Table 1. Genetic manipulations were conducted as described previously28. Yeast 
strains were cultured in standard YP or SC medium supplemented with appropriate nutrients and either 
2% glucose, 2% galactose or 2% glycerol/lactate as a sole carbon source. Where indicated, yeast strains 
were transformed with pRS415-Oma1-Myc-6xHis, pRS415-Oma1-Myc-6xHis H203A28, pRS426-Rcf114 
and pRS423-Cox5a49 plasmids.
Yeast Assays. The respiratory competence of indicated yeast strains was assessed by growth tests on 
YP plates containing 2% glucose, 2% galactose or 2% glycerol/2% lactate as a carbon source. Synchronized 
yeast cells were grown for indicated period of time at 28 °C in liquid medium containing glucose, adjusted 
to A600 of 1.0 and serially diluted and spotted onto the respective plates. The plates were incubated at 
28 °C for 2 days (YPD and YPGal) or 4–6 days (YPGL). Alternatively, aliquots of the yeast culture were 
diluted to 600 cells and plated onto YPD or YPGL plates. The colony forming units were scored follow-
ing 2 (YPD) or 4 (YPGL) days incubation at 28oC. The oxygen consumption of yeast strains in question 
was determined using an Oxygraph system (Hansatech Instruments) according to the manufacturer’s 
instructions. The rate of oxygen consumption (presented as % of wild type) was calculated from the lin-
ear response. In vivo labeling of mitochondrial translation products was done as described previously49.
Flow Cytometry. The fluorescence-assisted sorting was done with BD FACSCantoTM II system 
(Becton Dickinson). The measurements were performed using 1 ml of exponentially grown yeast cells 
diluted in 900 μ l of pre-warmed PBS (28oC). Accumulation of superoxide was measured using DHE 
(Cayman Chemical) as described previously41. Briefly, 1 ml the yeast culture was incubated with 5 μ g 
DHE for 10 min at 30 °C. Fluorescence intensity was measured in the FL2 channel (PE). Analysis of 
mitochondrial membrane potential was performed with JC-1 (Enzo Life Sciences) in the FL1 (FITC) 
and FL2 (PE) channels according to the manufacturer’s instructions. Prior to the analysis, 1 ml of yeast 
cells in PBS was incubated with 0.5 μ g JC-1 for 15 min at 37 °C. The percentage of depolarized cells was 
calculated from the ratio of FITC-positive cells to PE-positive cells. The data were collected, analyzed 
and plotted using BD FACSDiva software v6.1.1 (Becton Dickinson).
Zebrafish Maintenance and Care. Wild-type zebrafish (AB strain) were obtained from the Zebrafish 
International Resource Center (supported by NIH grant P40RR012546). Fish were maintained and 
crossed according to standard methods50. All animal studies were approved by the MUSC Institutional 
Animal Care and Use Committee (AR #2850) and performed in accordance with the guidelines. 
Fertilized eggs were collected and placed in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2, 0.33 mM MgSO4), and maintained in an incubator set at 28.5 °C with a 14/10 h light/dark cycle. 
Embryos were staged using the criteria of Kimmel et al.51. The standard control morpholino (Control; 
5′ - CCTCTTACCTCAGTTACAATTTATA-3′ ) and Oma1 translation-blocking morpholino (OMA1 TB; 
5′ -TCTTCTGCAAGGGCTTCAGCACCAT-3′ ) were designed with and obtained from Gene Tools, LLC. 
Morpholinos were diluted in sterile distilled H2O to a stock concentration of 6 mM and further diluted 
to 1 mM. Working solutions of phenol red were prepared by diluting neat phenol red (Sigma) 1:10 with 
1x sterile Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES, 
pH 7.2). Morpholinos were titrated to determine the amount of morpholino required for phenotypic 
differences without toxicity. 3 nL Oma1 TB or control morpholino was injected into the 1–4 cell stage 
embryo (< 0.5 hpf). Final concentration of morpholino in injection solution was 0.2 mM for TB or con-
trol by dilution with phenol red. Embryos/larvae were viewed using a Zeiss Axio Observer A.1 inverted 
microscope with 2.5× and 10× objectives.
Heart rates were measured by counting the number of atrial contractions in 30 seconds in embryos or 
larvae under 100× magnification. Zebrafish eye size was determined using Axiovision software (Zeiss). 
Individual images of embryos or larvae were examined and a free-hand circle drawn around the circum-
ference of each eye. The program calculated the area of each circle and the mean values were plotted. To 
determine body length of larvae, a line was drawn from the tip of the nose to the caudal peduncle of each 
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larvae and the measurement collected and converted to mm based on a micrometer scale. For protein 
extraction, 20 embryos were pooled for each time point, de-yolked, flash-frozen and stored at − 80 °C.
Metabolic Assays. The oxygen consumption rates (OCR) or extracellular acidification rates (ECAR) 
were determined using XF24-3 Analyzer (Seahorse Biosciences). 5 × 104 WT or oma1−/− MEFs were 
incubated in DMEM containing 4 mM L-glutamine, 1% NEAA, 1% penicillin-streptomycin and either 
10 mM glucose or 10 mM galactose for 72 h prior to plating cells in 24-well XF microplate. After an over-
night incubation in microplate, MEFs were switched over to bicarbonate-free low buffer DMEM contain-
ing either 10 mM glucose or 10 mM galactose. OCR and ECAR measurements were performed prior to 
and after consecutive injections of 1 μ M Oligomycin A and 1 μ M FCCP and 1 mM 2-deoxy-D-Glucose 
(2-DG) utilizing a 4–2-2 minute mix-wait-measure cycle. Measurements for wells treated with vehicle only 
were done in duplicate, whereas measurements for drug-treated wells were carried out in quadruplicate.
Isolation of Mitochondria and Assays. Yeast mitochondria were isolated according to published 
protocol52. For isolation of mammalian mitochondria, 4 × 107 MEFs were cultured in DMEM/F-12 
media supplemented with 10% (v/v) fetal bovine serum, penicillin (200 U/ml), streptomycin (200 μ g/ml), 
2 mM L-glutamine, and 200 μ M β -mercaptoethanol. MEFs were released with trypsin, washed twice 
with PBS and resuspended in homogenization buffer (10 mM HEPES, pH 7.5, 250 mM sucrose, 10 mM 
MgCl2, 10 mM KCl, 1 mM EDTA and 2 mM PMSF). The cells were then disrupted and mitochondria 
isolated as described9. BN-PAGE analyses were performed as described53. Unless specified, all gels have 
been run under the same experimental conditions. Specific activities of respiratory chain enzymes were 
determined according to published procedures54.
Phospholipid Analyses. Phospholipid extraction, staining, and quantitation were performed 
essentially as described15. In brief, phospholipids were extracted from 1 mg of mitochondria with 
chloroform:methanol, loaded onto ADAMANT TLC plates (Machery-Nagel), and resolved once in chloro-
form:ethanol: H2O:triethylamine (30:35:7:35). Phospholipids were visualized using a 1.3% molybdenum 
blue spray reagent (Sigma). Phosphate concentration of extracted lipids was performed as described55.
Immunoblotting. Proteins or protein complexes were detected with indicated primary antibod-
ies and visualized with horseradish peroxidase-coupled secondary antibodies and chemilumines-
cent reagents (Millipore). The following primary antibodies were used: α -Myc (#11667203001; Roche 
Diagnostics); α -Cox1 (ab110270), α -Cox2 (ab110271), α -Cox3 (ab110259), α -MTCO1 (ab14705), 
α -NDUFA9 (ab14713), α -COXIV (ab16056), α -CORE1 (ab110252) and α -ATP5A (ab14748) from 
Abcam; α -OMA1 (ARP52818_P050; Aviva Systems Biology); α -Porin (#459500; Invitrogen); α -OPA1 
(NB110-55290; Novus Biologicals); and α -β -Actin (A2228; Sigma). The polyclonal antibodies against 
Atp2 (anti-F1) subunit of complex V, Cyt1 and Rip1 subunits of complex III, and Sdh2 subunit of com-
plex II were kind gifts from Drs. Alex Tzagoloff (Columbia University), Carla Koehler (UCLA) and 
Dennis Winge (University of Utah), respectively. Obtained images were scanned and cropped for the 
figures with cropping lines indicated. Images of full-length blots for key data of each figure are available 
in the Supplementary information.
Statistical Analyses. Statistical analyses were conducted using Microsoft Excel. At least three 
independent replicates have been obtained for each presented experiment. Data are presented as 
means ± standard error of the mean (S.E.M.) or ± standard deviation (S.D.). Statistical significance was 
determined using Student’s t-test and considered significant at p ≤ 0.05.
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